Speed and Safety in Drug Approval and Commercialization

Pediatrics. 2017 Nov;140(5):e20170791. doi: 10.1542/peds.2017-0791. Epub 2017 Oct 11.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Bone Neoplasms / therapy*
  • Child
  • Clinical Trials as Topic / organization & administration*
  • Clinical Trials as Topic / standards
  • Clinical Trials, Phase II as Topic
  • Combined Modality Therapy
  • Drug Approval / legislation & jurisprudence
  • Drug Approval / methods*
  • Drug Approval / organization & administration*
  • Efficiency, Organizational / legislation & jurisprudence
  • Efficiency, Organizational / statistics & numerical data*
  • Female
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / therapy*
  • Male
  • Osteosarcoma / secondary*
  • Osteosarcoma / therapy*
  • Patient Safety
  • Politics*
  • Technology Transfer*
  • Therapies, Investigational / methods*
  • Time Factors
  • United States
  • United States Food and Drug Administration
  • Young Adult